ArticleCell genomics2026
Cross-task interpretability through unified modeling reveals a universal shortcut bias in neoantigen prediction.
Article in Cell genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Causal AI for cancer immunotherapy: a narrative framework review of target trial emulation, treatment-effect learning and clinical translation.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate neoantigen prediction is central to the design of personalized cancer immunotherapy. The immune recognition of neoantigens is a multi-step process involving peptide-major histocompatibility complex (MHC) binding, antigen presentation, and T cell activation. Despite extensive computational efforts, the overall accuracy of neoantigen identification remains unsatisfactory, limiting translational potential. Here, we present ImmUni, a unified transformer-based framework that models the three immunological stages within a consistent architecture. Through this unified modeling, we discovered that deep-learning-based immunogenicity predictors have inadvertently learned shortcut correlations driven by intra-human leukocyte antigen (intra-HLA) label imbalance, revealing a previously unrecognized model-agnostic source of bias. We quantified this bias using an information-theoretic metric and proposed a mutual-information-guided debiasing strategy that mitigates shortcut learning and improves mutation-level generalization. ImmUni not only identifies the shortcut bias issue in current neoantigen prediction but also defines a general methodological framework for diagnosing and correcting bias across data-limited, multi-step tasks in computational biology scenarios.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.